Jeremy Tatum has more than 18 years of commercial experience in the pharmaceutical industry.
Prior to TriRx, Mr. Tatum served as VP, Commercial and Portfolio for SunGen Pharma, where he managed multiple licensing deals in the US and abroad. Before SunGen, he ran the global serialization project for Par Pharmaceutical, a project that spanned five manufacturing locations, two distribution centers and over 30 CMOs.
He joined Par Pharmaceutical as Director of Sales Operations following the company’s merger with Qualitest Pharmaceuticals, where he spent 14 years in roles of increasing responsibility, including Sales Representative, Sales and Marketing Manager, and, finally, Director of Market Insights, a role in which he strongly supported the company’s growth from $250 million to over $1.2 billion in net sales through multiple BD deals, AG launches and licensing agreements. Mr. Tatum grew up working in his family’s independent pharmacies and holds a B.S. degree in marketing from Tennessee Technological University.